What is Dare Bioscience Inc (DARE) stock price today?

Dare Bioscience Inc (DARE) currently trades at $2.28 per share. The stock has a market capitalization of $30.72M and a P/E ratio of —x.

Is DARE stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Dare Bioscience Inc has a Smart Value Score of 13/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Dare Bioscience Inc's revenue and earnings?

Dare Bioscience Inc has trailing twelve-month (TTM) revenue of $1.03M with profit margins of 0.00%. Earnings per share (EPS) is $-1.20.

DARE

Dare Bioscience Inc

NASDAQ: DARE · HEALTHCARE · BIOTECHNOLOGY

$2.28

+8.57% today

Updated 2026-04-30

Market cap

$30.72M

P/E ratio

—

P/S ratio

29.82x

EPS (TTM)

$-1.20

Dividend yield

—

52W range

$1 – $3

Volume

0.4M

Market cap

$30.72M

P/E ratio

—

P/S ratio

29.82x

EPS (TTM)

$-1.20

Dividend yield

—

52W range

$1 – $3

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$9.67

+324.12%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $1.24M — positive

Risks

- Thin margins at 0.00%

- Revenue declining -94.60% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$10.00M	$2.81M	$9784.00	$1.03M	$1.03M
Net income	$406.80M	$-30.16M	$-4.05M	$-13.40M	$-1.44M
EPS	—	—	—	—	$-1.20
Free cash flow	$-18.15M	$-39.49M	$4.82M	$-10.27B	$1.24M
Profit margin	4,068.02%	-1,074.17%	-41,430.90%	-1,300.66%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DARE	$30.72M	13	2.7	2.5	5.0	5.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Dare Bioscience Inc trades at $2.28. Our Smart Value Score of 13/100 indicates the stock is weak. TTM revenue stands at $1.03M.

Frequently asked questions

What is Dare Bioscience Inc's stock price?

Dare Bioscience Inc (DARE) trades at $2.28.

Is Dare Bioscience Inc overvalued?

Smart Value Score 13/100 (Grade F, Strong Sell).

What is the price target of Dare Bioscience Inc (DARE)?

The analyst target price is $9.67, representing +324.1% upside from the current price of $2.28.

What is Dare Bioscience Inc's revenue?

TTM revenue is $1.03M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio29.82x

ROE-2,543.00%

Beta0.90

50D MA$1.74

200D MA$1.99

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

DARE vs LLY →DARE vs JNJ →DARE vs ABBV →Stock screener →